160968-91-2 Usage
Description
Ethanone, 1-[7-amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]-, is a chemical compound with the molecular formula C13H18BrN3O. It is a derivative of indole, a heterocyclic compound commonly found in plant-based foods and natural products. This particular compound features an amino group at the 7th position attached to a dihydroindolyl group, with a bromopropyl substituent. Its unique structure suggests potential applications in pharmaceutical research and development, given its similarities to other biologically active compounds and possible therapeutic properties. Further investigation and testing are required to fully understand its chemical and biological properties.
Uses
Used in Pharmaceutical Research and Development:
Ethanone, 1-[7-amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]is used as a research compound for exploring its potential therapeutic properties. Its structural similarities to other biologically active compounds make it a promising candidate for the development of new drugs.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Ethanone, 1-[7-amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]is used as a starting material or intermediate in the synthesis of novel pharmaceutical agents. Its unique functional groups and structural features can be further modified to create new compounds with improved pharmacological properties.
Used in Drug Discovery:
Ethanone, 1-[7-amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]is used as a lead compound in drug discovery programs. Its potential biological activities and interactions with biological targets can be investigated to identify new therapeutic agents for various diseases and conditions.
Used in Chemical Synthesis:
In the field of chemical synthesis, Ethanone, 1-[7-amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]is used as a building block or precursor in the preparation of more complex organic molecules. Its versatile structure allows for various synthetic transformations, enabling the development of new chemical entities with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 160968-91-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,9,6 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 160968-91:
(8*1)+(7*6)+(6*0)+(5*9)+(4*6)+(3*8)+(2*9)+(1*1)=162
162 % 10 = 2
So 160968-91-2 is a valid CAS Registry Number.
160968-91-2Relevant articles and documents
Aza-bicycles which modulate the inhibition of cell adhesion
-
, (2008/06/13)
The invention is directed to physiologically active compounds of formula (I) wherein R1represents R3—Z3—, R3—L2—R4—Z3—, R3—L3—Ar1—L4—Z3— or R3—L3—Ar1—L2—R4—Z3—; R2represents hydrogen, halogen, lower alkyl or lower alkoxy; A1represents a straight chain C1-3alkylene linkage optionally substituted by one or more groups chosen from alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, imino, oxo, thioxo, or alkyl substituted by —ZR6, —NY1Y2, —CO2R6or —C(═O)—NY1Y2; L1represents a direct bond; an alkenylene, alkylene, alkynylene, cycloalkenylene, cycloalkylene, heteroaryldiyl, heterocycloalkylene or arylene linkage each optionally substituted by (a) an acidic functional group, cyano, oxo, —S(O)mR9, R3, —C(═O)—R3, —C(═O)—OR3, —N(R8)—C(═O)R9, —N(R8)—SO2—R9, —NY4Y5or —[C(═O)—N(R10)—C(R5)(R11)]p—C(═O)—NY4Y5, or by (b) alkyl substituted by an acidic functional group, or S(O)mR9, —C(═O)—NY4Y5or —NY4Y5; a —[C(═O)—N(R10)—C(R5)(R11)]p— linkage; a —Z2—R12— linkage; a —C(═O)—CH2—C(═O)— linkage; a —R12—Z2—R12— linkage; a —C(R4)(R13)—[C(═O)—N(R10)—C(R5)(R11)]p— linkage; or a —L5—L6—L7— linkage; Z1is C(R7)(R7a), C(═O) or CH(OH); Y is carboxy or an acid bioisostere; and the corresponding N-oxides, and their prodrugs; and pharmaceutically acceptable salts and solvates of such compounds and their N-oxides and prodrugs. Such compounds have valuable pharmaceutical properties, in particular the ability to regulate the interaction of VCAM-1 and fibronectin with the integrin VLA-4 (α4β1).
